DOBI Medical International Showcases ComfortScan ® System at San Antonio Breast Cancer Symposium
Mahwah, NJ, December 6, 2005 – Breast imaging developer DOBI Medical International, Inc. (DBMI.OB) will showcase its latest ComfortScan ® technology at the 28th Annual San Antonio Breast Cancer Symposium (SABCS), December 8-10, at the Henry B. Gonzalez Convention Center, San Antonio (booth #207). Now DICOM-compliant and with new display algorithms, the ComfortScan system, which is limited to investigational use in the U.S., is a noninvasive and non x-ray dynamic optical breast imaging system designed to assist physicians in the diagnosis and management of breast cancer.
The ComfortScan system uses high-intensity, light-emitting diodes (LEDs) and gentle external pressure to identify vascular abnormalities or tumor angiogenesis (the growth of new blood vessels) in the breast. This blood vessel growth is often associated with malignant breast tumors. Because standard technologies, such as mammography and ultrasound do not show this growth, the ComfortScan system has the potential to improve the physician’s diagnosis of breast cancer when used as an adjunct to mammography. According to the American Cancer Society, more than 211,000 women in the U.S. alone are found to have invasive breast cancer every year.
Sponsored by the San Antonio Cancer Institute and Baylor College of Medicine, SABCS provides state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and pre-malignant breast disease to an international audience of academic and private physicians and researchers. For more conference information, visit www.sabcs.org.
About DOBI Medical International,
CAUTIONARY STATEMENT FOR FORWARD-LOOKING STATEMENTS
Any one of these or other risks, uncertainties, other factors, and any inaccurate assumptions, may cause actual results to be materially different from those described herein or elsewhere by us. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in our filings from time to time with the Securities and Exchange Commission, which we strongly urge you to read and consider, including the "Investment Considerations" and the "Cautionary Factors That May Affect Future Results" as set forth in our 2004 Annual Report on Form 10-KSB, as amended, and the "Risk Factors" in our Registration Statement on Form SB-2 declared effective on May 11, 2005, our Quarterly Reports on 10-QSB, and our Current Reports on Form 8-K, all of which may be accessed from our website at igaot.pt. Subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above and elsewhere in our reports filed with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.
For further information:
DOBI Medical International